Literature DB >> 19672150

Comparison of carbon ions versus protons.

Uli Weber1, Gerhard Kraft.   

Abstract

At present, beam ion beam therapy has started to spread worldwide. In Europe and Asia, combined carbon/proton facilities are favored, but in the US, only proton centers are under construction. This development is partially due to the different funding procedures and partially due to the more complex physical and especially biologic features of the heavy ions. In this article, the basic properties of both ions are presented, and their features for therapy are outlined. This refers to the dose conformity, the general precision of the treatment, and the ability to monitor via in-beam positron emission tomography the ions range inside the patient. Then the very complex biologic features are treated, and, finally, the treatment plans are compared.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672150     DOI: 10.1097/PPO.0b013e3181b01935

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  21 in total

1.  Comparative Risk Predictions of Second Cancers After Carbon-Ion Therapy Versus Proton Therapy.

Authors:  John G Eley; Thomas Friedrich; Kenneth L Homann; Rebecca M Howell; Michael Scholz; Marco Durante; Wayne D Newhauser
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-16       Impact factor: 7.038

Review 2.  Re-irradiation with protons or heavy ions with focus on head and neck, skull base and brain malignancies.

Authors:  Katharina Seidensaal; Semi Ben Harrabi; Matthias Uhl; Juergen Debus
Journal:  Br J Radiol       Date:  2019-11-12       Impact factor: 3.039

Review 3.  Heavy charged particle radiobiology: using enhanced biological effectiveness and improved beam focusing to advance cancer therapy.

Authors:  Christopher Allen; Thomas B Borak; Hirohiko Tsujii; Jac A Nickoloff
Journal:  Mutat Res       Date:  2011-03-03       Impact factor: 2.433

4.  Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errors.

Authors:  Thomas J Pugh; Richard A Amos; Sandra John Baptiste; Seungtaek Choi; Quyhn Nhu Nguyen; X Ronald Zhu; Matthew B Palmer; Andrew K Lee
Journal:  Med Dosim       Date:  2013-06-06       Impact factor: 1.482

5.  Apoptosis and expression of apoptosis-related genes in mouse intestinal tissue after whole-body proton exposure.

Authors:  Ashley Purgason; Ye Zhang; Stanley R Hamilton; Daila S Gridley; Ayodotun Sodipe; Olufisayo Jejelowo; Govindarajan T Ramesh; Maria Moreno-Villanueva; Honglu Wu
Journal:  Mol Cell Biochem       Date:  2017-11-02       Impact factor: 3.396

6.  Development of Ultra-High Dose-Rate (FLASH) Particle Therapy.

Authors:  Michele M Kim; Arash Darafsheh; Jan Schuemann; Ivana Dokic; Olle Lundh; Tianyu Zhao; José Ramos-Méndez; Lei Dong; Kristoffer Petersson
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2021-06-22

Review 7.  Particle therapy in the future of precision therapy.

Authors:  Lukas Schaub; Semi Ben Harrabi; Juergen Debus
Journal:  Br J Radiol       Date:  2020-08-14       Impact factor: 3.629

8.  Photon, light ion, and heavy ion cancer radiotherapy: paths from physics and biology to clinical practice.

Authors:  Jac A Nickoloff
Journal:  Ann Transl Med       Date:  2015-12

Review 9.  Range Verification Methods in Particle Therapy: Underlying Physics and Monte Carlo Modeling.

Authors:  Aafke Christine Kraan
Journal:  Front Oncol       Date:  2015-07-07       Impact factor: 6.244

10.  Dosimetric impact of reduced nozzle-to-isocenter distance in intensity-modulated proton therapy of intracranial tumors in combined proton-carbon fixed-nozzle treatment facilities.

Authors:  Urszula Jelen; Marta E Bubula; Filippo Ammazzalorso; Rita Engenhart-Cabillic; Uli Weber; Andrea Wittig
Journal:  Radiat Oncol       Date:  2013-09-18       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.